RU2009133256A - Новые 2-гетероарил-замещенные индолы 695 - Google Patents
Новые 2-гетероарил-замещенные индолы 695 Download PDFInfo
- Publication number
- RU2009133256A RU2009133256A RU2009133256/04A RU2009133256A RU2009133256A RU 2009133256 A RU2009133256 A RU 2009133256A RU 2009133256/04 A RU2009133256/04 A RU 2009133256/04A RU 2009133256 A RU2009133256 A RU 2009133256A RU 2009133256 A RU2009133256 A RU 2009133256A
- Authority
- RU
- Russia
- Prior art keywords
- fluoroalkyl
- alkyl
- nhc
- methyl
- fluoro
- Prior art date
Links
- 150000002475 indoles Chemical class 0.000 title 1
- 125000003709 fluoroalkyl group Chemical group 0.000 claims abstract 65
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims abstract 31
- 125000000217 alkyl group Chemical group 0.000 claims abstract 27
- -1 hydroxy, methoxy Chemical group 0.000 claims abstract 20
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims abstract 17
- 150000001875 compounds Chemical class 0.000 claims abstract 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract 15
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract 8
- 125000002947 alkylene group Chemical group 0.000 claims abstract 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract 6
- 125000005843 halogen group Chemical group 0.000 claims abstract 4
- 229910052799 carbon Inorganic materials 0.000 claims abstract 3
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract 3
- 125000003545 alkoxy group Chemical group 0.000 claims 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 8
- 125000004429 atom Chemical group 0.000 claims 5
- 125000001246 bromo group Chemical group Br* 0.000 claims 5
- 239000000470 constituent Substances 0.000 claims 5
- 125000001153 fluoro group Chemical group F* 0.000 claims 5
- 239000012453 solvate Substances 0.000 claims 4
- 125000002346 iodo group Chemical group I* 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- PQQYTZOQBOERJZ-UHFFFAOYSA-N 2-[6-(methylamino)pyridin-3-yl]-1h-indol-5-ol Chemical compound C1=NC(NC)=CC=C1C1=CC2=CC(O)=CC=C2N1 PQQYTZOQBOERJZ-UHFFFAOYSA-N 0.000 claims 2
- AMSTWUVZBSJAPO-UHFFFAOYSA-N 5-(1h-indol-2-yl)pyridine-2-carboxamide Chemical compound C1=NC(C(=O)N)=CC=C1C1=CC2=CC=CC=C2N1 AMSTWUVZBSJAPO-UHFFFAOYSA-N 0.000 claims 2
- VNLDZPGDHVKUHH-UHFFFAOYSA-N 5-(5-fluoro-1h-indol-2-yl)-n-methylpyridin-2-amine Chemical compound C1=NC(NC)=CC=C1C1=CC2=CC(F)=CC=C2N1 VNLDZPGDHVKUHH-UHFFFAOYSA-N 0.000 claims 2
- SZCASYJKGSDWRF-UHFFFAOYSA-N 5-(5-fluoro-1h-indol-2-yl)pyridine-2-carboxamide Chemical compound C1=NC(C(=O)N)=CC=C1C1=CC2=CC(F)=CC=C2N1 SZCASYJKGSDWRF-UHFFFAOYSA-N 0.000 claims 2
- BKYRONJOTOZEGB-UHFFFAOYSA-N 5-(5-methoxy-1h-indol-2-yl)-n-methylpyridin-2-amine Chemical compound C1=NC(NC)=CC=C1C1=CC2=CC(OC)=CC=C2N1 BKYRONJOTOZEGB-UHFFFAOYSA-N 0.000 claims 2
- 125000004414 alkyl thio group Chemical group 0.000 claims 2
- 239000012458 free base Substances 0.000 claims 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- SDHHYFPFMMHZBX-UHFFFAOYSA-N tert-butyl 2-(6-carbamoylpyridin-3-yl)-5-fluoroindole-1-carboxylate Chemical compound C=1C2=CC(F)=CC=C2N(C(=O)OC(C)(C)C)C=1C1=CC=C(C(N)=O)N=C1 SDHHYFPFMMHZBX-UHFFFAOYSA-N 0.000 claims 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- 125000004455 (C1-C3) alkylthio group Chemical group 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- 208000037259 Amyloid Plaque Diseases 0.000 claims 1
- XCUAIINAJCDIPM-XVFCMESISA-N N(4)-hydroxycytidine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=NO)C=C1 XCUAIINAJCDIPM-XVFCMESISA-N 0.000 claims 1
- XAKBSHICSHRJCL-UHFFFAOYSA-N [CH2]C(=O)C1=CC=CC=C1 Chemical group [CH2]C(=O)C1=CC=CC=C1 XAKBSHICSHRJCL-UHFFFAOYSA-N 0.000 claims 1
- 230000003941 amyloidogenesis Effects 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical class I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 238000003384 imaging method Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 238000002595 magnetic resonance imaging Methods 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000001209 o-nitrophenyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])[N+]([O-])=O 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 238000004611 spectroscopical analysis Methods 0.000 claims 1
- KLPQADIFPSBTPY-UHFFFAOYSA-N tert-butyl 5-methoxy-2-[6-(methylamino)pyridin-3-yl]indole-1-carboxylate Chemical compound C1=NC(NC)=CC=C1C1=CC2=CC(OC)=CC=C2N1C(=O)OC(C)(C)C KLPQADIFPSBTPY-UHFFFAOYSA-N 0.000 claims 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 4
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 2
- 125000000565 sulfonamide group Chemical group 0.000 abstract 2
- CLXVQMSNBCCFDS-UHFFFAOYSA-N COC(c1ccc(-c2cc3cc(O)ccc3[nH]2)nc1)=O Chemical compound COC(c1ccc(-c2cc3cc(O)ccc3[nH]2)nc1)=O CLXVQMSNBCCFDS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89315107P | 2007-03-06 | 2007-03-06 | |
| US60/893,151 | 2007-03-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2009133256A true RU2009133256A (ru) | 2011-04-20 |
Family
ID=39738509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009133256/04A RU2009133256A (ru) | 2007-03-06 | 2008-03-05 | Новые 2-гетероарил-замещенные индолы 695 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100098631A1 (zh) |
| EP (1) | EP2121655A4 (zh) |
| JP (1) | JP2010520275A (zh) |
| KR (1) | KR20090115954A (zh) |
| CN (1) | CN101636395A (zh) |
| AU (1) | AU2008221667A1 (zh) |
| BR (1) | BRPI0808090A2 (zh) |
| CA (1) | CA2680055A1 (zh) |
| MX (1) | MX2009009113A (zh) |
| RU (1) | RU2009133256A (zh) |
| WO (1) | WO2008108729A1 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011524864A (ja) | 2008-05-30 | 2011-09-08 | メルク・シャープ・エンド・ドーム・コーポレイション | 新規な置換されたアザベンゾオキサゾール |
| AR072297A1 (es) | 2008-06-27 | 2010-08-18 | Novartis Ag | Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona. |
| JP2012504137A (ja) * | 2008-09-29 | 2012-02-16 | アボット・ラボラトリーズ | インドール誘導体およびインドリン誘導体ならびにそれらの使用方法 |
| EP2501696B1 (en) | 2009-10-15 | 2016-12-28 | Guerbet | Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases |
| CN114380731B (zh) * | 2022-03-09 | 2024-07-02 | 台州学院 | 一种kcnq钾离子通道激动剂、药物组合物及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6696039B2 (en) * | 2001-04-23 | 2004-02-24 | Trustees Of The University Of Pennsylvania | Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| CA2438032C (en) * | 2003-03-14 | 2013-05-07 | University Of Pittsburgh | Benzothiazole derivative compounds, compositions and uses |
| WO2006125324A1 (en) * | 2005-05-27 | 2006-11-30 | Queen's University At Kingston | Treatment of protein folding disorders |
-
2008
- 2008-03-05 CN CN200880007424A patent/CN101636395A/zh active Pending
- 2008-03-05 BR BRPI0808090-9A2A patent/BRPI0808090A2/pt not_active IP Right Cessation
- 2008-03-05 RU RU2009133256/04A patent/RU2009133256A/ru not_active Application Discontinuation
- 2008-03-05 WO PCT/SE2008/050242 patent/WO2008108729A1/en active Application Filing
- 2008-03-05 EP EP08724189A patent/EP2121655A4/en not_active Withdrawn
- 2008-03-05 CA CA002680055A patent/CA2680055A1/en not_active Abandoned
- 2008-03-05 MX MX2009009113A patent/MX2009009113A/es not_active Application Discontinuation
- 2008-03-05 US US12/529,850 patent/US20100098631A1/en not_active Abandoned
- 2008-03-05 AU AU2008221667A patent/AU2008221667A1/en not_active Abandoned
- 2008-03-05 JP JP2009552640A patent/JP2010520275A/ja active Pending
- 2008-03-05 KR KR1020097018582A patent/KR20090115954A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20100098631A1 (en) | 2010-04-22 |
| EP2121655A4 (en) | 2010-09-22 |
| CN101636395A (zh) | 2010-01-27 |
| KR20090115954A (ko) | 2009-11-10 |
| WO2008108729A1 (en) | 2008-09-12 |
| CA2680055A1 (en) | 2008-09-12 |
| JP2010520275A (ja) | 2010-06-10 |
| AU2008221667A1 (en) | 2008-09-12 |
| EP2121655A1 (en) | 2009-11-25 |
| BRPI0808090A2 (pt) | 2014-06-17 |
| MX2009009113A (es) | 2009-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2009124537A (ru) | НОВЫЕ ГЕТЕРОАРИЛЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ ИМИДАЗО(1,2-a)ПИРИДИНОВ | |
| RU2448106C2 (ru) | Новые гетероарил-замещенные бензотиазолы | |
| JP2010520276A5 (zh) | ||
| SI3099687T1 (en) | MACROCYCLES WITH HETEROCYCLIC P2 'GROUPS AS FACTOR XIA INHIBITORS | |
| AR042052A1 (es) | Diaminotriazoles utiles como inhibidores de proteinquinasas | |
| JP2004516314A5 (zh) | ||
| RU2009133256A (ru) | Новые 2-гетероарил-замещенные индолы 695 | |
| RU2009105826A (ru) | 2,4-ди(ариламино)питимидин-5-карбоксамидные соединения в качестве ингибиторов jak-киназ | |
| RU2018121499A (ru) | Гипоксантины в качестве ингибиторов убиквитин-специфической протеазы 1 | |
| RU2007124492A (ru) | Комбинации, включающие эпотилоны и ингибиторы протеинтирозинкиназы, и их фармацевтическое применение | |
| RU2012110246A (ru) | Замещенные бензоазепины в качестве модуляторов toll-подобного рецептора | |
| RU2009102943A (ru) | Производные фенола для лечения респираторных заболеваний | |
| JP2009541309A5 (zh) | ||
| JP2006507265A5 (zh) | ||
| JP2009545611A5 (zh) | ||
| RU2009109160A (ru) | Инсектицидные изоксазолины | |
| JP2009536620A5 (zh) | ||
| JP2008525417A5 (zh) | ||
| AR057433A1 (es) | Compuestos quimicos derivados de piridopirimidina, un metodo para su preparacion y composicion farmaceutica | |
| RU2007104107A (ru) | Тиофлавиновые производные, являющиеся суррогатными маркерами амилоидных отложений (варианты), способ определения эффективности терапевтического лечения амилоидоза (варианты) и способ выявления пациента, находящегося в продромальной стадии заболевания, ассоциированного с отложением амилоида | |
| RU2008144584A (ru) | 4,5-дигидро-[1,2,4]триазоло[4,3-f]птеридины в качестве ингибиторов протеинкиназы plk1 для лечения пролиферативных заболеваний | |
| RU2019100164A (ru) | Гетероциклическое соединение, используемое как ингибитор fgfr | |
| RU2009146124A (ru) | Дигидрохиноновые и дигидронафтиридиновые ингибиторы киназы jnk | |
| AR035254A1 (es) | Derivados fluorquinolonicos de oxazolidinonas utiles como antibacterianos, procedimiento para su obtencion y su utilizacion para la preparacion de una composicion farmaceutica | |
| NO20063330L (no) | Amidderivater med en syklopropylaminokarbonylsubstituent som er nyttige som cytokininhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20110524 |